Skip to main content

What our clients say

“Developing the CapCell proposal was a long but very fruitful and exciting journey. It was very valuable to have the accelopment team on board, providing great support, contributions and flexibility. Achieving a perfect 15/15 score and ranking first among 23 proposals owes a lot to their efforts.“

Dr. Athina Vidaki

CapCell Project Coordinator
Maastricht University, Netherlands

Innovative forensic trace investigation via microfluidics and single-cell genomics

Sexual violence affects 1 in 10 women across Europe and has increased by 10% alone in 2021-2022. Most cases involve complex biological mixtures containing cells from the victim and perpetrator(s). Current forensic methods struggle to isolate individual DNA profiles, leaving many cases unresolved and perpetrators unprosecuted. Addressing these limitations is critical to improving evidence interpretation, ensuring justice for victims, and reducing societal impacts.

CapCell aims to deliver a new approach to improve forensics and lawful evidence collection with innovative microfluidics and single-cell genomics technologies to overcome the limitations of mixed DNA evidence.

Specifically, we will develop the CapCell toolkit comprised of ten easily integrated modules that capture, select, isolate, sequence and interpret individual cells of interest. We will co-create novel strategies and best practices with end-users and industry to improve evidence collection from postcoital swabs and contact traces. Recovered intact cells from male contributors will then be selected and isolated using innovative mobile microfluidic devices. By employing novel concepts, we will advance follow-up DNA sequencing assays and analysis tools to target diverse forensic biomarkers with single-cell resolution. We will align interpretation frameworks to suit single-cell DNA analysis and leverage machine learning to automate the forensic process. Eventually, CapCell will achieve its goal by validating and implementing the new toolkit (TRL5-7) in the relevant end-user environment, with the support of several forensic science institutes and police forces.

To reach its ambitious objectives, CapCell brings together an experienced intersectoral consortium of 13 partners from 8 European countries, with complementary expertise in forensic genomics, biosensor technology, bioinformatics, statistics and technology prototyping. Ultimately, CapCell will contribute to a safer and healthier society across Europe.

This project contributes to the UN Sustainable Development Goals (SDGs) 5, 16 and 3.

Facts

Programme:

HORIZON-SECURITY-2024-FCT

Duration:

01.10.2025 – 30.09.2029

Budget:

4.94 million euro

Area:

Security, forensic, genetics

Our Services:

Proposal Writing
Grant Preparation
Management
Dissemination

Coordinator

Maastricht University, NL

Partners

Catholic University of Leuven, BE
Institute for Research and Innovation in Health, PT
Medical University of Innsbruck, AT
Netherlands Forensic Institute, NL
Estonia Forensic Science Institute, EE
Estonian Police and Border Guard Board, EE
Austrian Federal Criminal Police, AT
COPAN Italia S.p.a., IT
NimaGen B.V., NL
Voxdale GmbH, BE
European DNA Profiling Group, DE
accelopment Schweiz AG, CH

Our Team

Ensuring the accessibility of valuable information derived from R&D is not only enriching but also a crucial aspect of effectively tackling societal challenges.

Alexandra Furio

Project Manager Communications & Development
Marie Skłodowska-Curie ActionsHealthDigital & Industry & Security
©accelopment Schweiz AG
+41 44 455 66 00 
info@accelopment.com  
ISO 9001 certified
© 2026 accelopment. All rights reserved.